Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 42
Filter
1.
Mol Syst Biol ; 15(8): e8939, 2019 08.
Article in English | MEDLINE | ID: mdl-31464369

ABSTRACT

Cells respond to environmental fluctuations by regulating multiple transcriptional programs. This response can be studied by measuring the effect of environmental changes on the transcriptome or the proteome of the cell at the end of the response. However, the dynamics of the response reflect the working of the regulatory mechanisms in action. Here, we utilized a fluorescent stress reporter gene to track the dynamics of protein production in yeast responding to environmental stress. The response is modulated by changes in both the duration and rate of transcription. We probed the underlying molecular pathways controlling these two dimensions using a library of ~1,600 single- and double-mutant strains. Dissection of the effects of these mutants and the interactions between them identified distinct modulators of response duration and response rate. Using a combination of mRNA-seq and live-cell microscopy, we uncover mechanisms by which Msn2/4, Mck1, Msn5, and the cAMP/PKA pathway modulate the response of a large module of stress-induced genes in two discrete regulatory phases. Our results and analysis show that transcriptional stress response is regulated by multiple mechanisms that overlap in time and cellular location.


Subject(s)
DNA-Binding Proteins/genetics , Gene Expression Regulation, Fungal , Glycogen Synthase Kinase 3/genetics , RNA, Messenger/genetics , Saccharomyces cerevisiae Proteins/genetics , Saccharomyces cerevisiae/genetics , Transcription Factors/genetics , Cyclic AMP/metabolism , Cyclic AMP-Dependent Protein Kinases/genetics , Cyclic AMP-Dependent Protein Kinases/metabolism , DNA-Binding Proteins/metabolism , Gene Expression Profiling , Gene-Environment Interaction , Genes, Reporter , Glycogen Synthase Kinase 3/deficiency , Green Fluorescent Proteins/genetics , Green Fluorescent Proteins/metabolism , Karyopherins/genetics , Karyopherins/metabolism , Mutation , Potassium Chloride/pharmacology , RNA, Messenger/metabolism , Saccharomyces cerevisiae/drug effects , Saccharomyces cerevisiae/metabolism , Saccharomyces cerevisiae Proteins/metabolism , Signal Transduction , Stress, Physiological , Transcription Factors/metabolism , Transcription, Genetic
2.
Int J Med Sci ; 16(6): 902-908, 2019.
Article in English | MEDLINE | ID: mdl-31337964

ABSTRACT

Diabetes mellitus (DM) is a principal health problem with increasing incidence worldwide. It can be associated with various systemic diseases. Long non-coding RNA (lncRNA), a member of non-coding RNA has been newly linked with various human diseases. Recent evidence from animal experiments has shown that the incidence and development of type 2 diabetes are contributed by the atypical expression of lncRNA in which the biomarker with capable clinical potential was lncRNA NONRATT021972. In this review, we demonstrated the numerous functions of NONRATT021972 in different diabetes-related diseases including diabetic neuropathy, diabetic cardiac autonomic neuropathy, myocardial ischemia, and hepatic glucokinase dysfunction. The emerging evidence shows that the role of NONRATT021972 in diabetic-related disease is novel and therapeutic. These results direct us to conclude that NONRATT021972 is a potential diagnostic and future targeted therapy for diabetes-associated diseases.


Subject(s)
Diabetes Mellitus, Experimental/genetics , Diabetes Mellitus, Type 2/genetics , Diabetic Neuropathies/genetics , Myocardial Ischemia/genetics , RNA, Long Noncoding/metabolism , Animals , Biomarkers/metabolism , Diabetes Mellitus, Experimental/complications , Diabetes Mellitus, Type 2/complications , Diabetes Mellitus, Type 2/epidemiology , Diabetic Neuropathies/diagnosis , Diabetic Neuropathies/epidemiology , Gene Expression Regulation , Glycogen Synthase Kinase 3/deficiency , Humans , Incidence , Myocardial Ischemia/diagnosis , Myocardial Ischemia/epidemiology , Rats
3.
Biochem Biophys Res Commun ; 503(3): 2068-2074, 2018 09 10.
Article in English | MEDLINE | ID: mdl-30119888

ABSTRACT

Medial vascular calcification is a highly regulated process involving osteo-/chondrogenic transdifferentiation of vascular smooth muscle cells. Both, protein kinase B (PKB) and serum- and glucocorticoid-inducible kinase 1 (SGK1) are involved in the intracellular signaling of vascular calcification and both phosphorylate and inactivate glycogen synthase kinase 3 (GSK-3). The present study explored whether PKB/SGK-dependent phosphorylation of GSK-3α/ß is involved in vascular calcification. Experiments were performed in Gsk-3α/ß double knockin mice lacking functional PKB/SGK phosphorylation sites (gsk-3KI) and corresponding wild-type mice (gsk-3WT) following high-dosed cholecalciferol treatment as well as ex vivo in aortic ring explants from gsk-3KI and gsk-3WT mice treated without and with phosphate. In gsk-3WT mice, high-dosed cholecalciferol induced vascular calcification and aortic osteo-/chondrogenic signaling, shown by increased expression of osteogenic markers Msx2, Cbfa1 and tissue-nonspecific alkaline phosphatase (Alpl). All these effects were suppressed in aortic tissue from gsk-3KI mice. Cholecalciferol decreased aortic Gsk-3α/ß phosphorylation (Ser21/9) in gsk-3WT mice, while no phosphorylation was observed in gsk-3KI mice. Moreover, the mRNA expression of type III sodium-dependent phosphate transporter (Pit1) and plasminogen activator inhibitor 1 (Pai1) was increased following cholecalciferol treatment in aortic tissue of gsk-3WT mice, effects again blunted in gsk-3KI mice. In addition, phosphate treatment induced mineral deposition and osteogenic markers expression in aortic ring explants from gsk-3WT mice, effects reduced in aortic ring explants from gsk-3KI mice. In conclusion, vascular PKB/SGK-dependent phosphorylation of GSK-3α/ß contributes to the osteoinductive signaling leading to vascular calcification.


Subject(s)
Cholecalciferol/metabolism , Glycogen Synthase Kinase 3 beta/metabolism , Glycogen Synthase Kinase 3/metabolism , Immediate-Early Proteins/metabolism , Protein Serine-Threonine Kinases/metabolism , Proto-Oncogene Proteins c-akt/metabolism , Vascular Calcification/metabolism , Animals , Cholecalciferol/administration & dosage , Glycogen Synthase Kinase 3/deficiency , Glycogen Synthase Kinase 3 beta/deficiency , Injections, Subcutaneous , Mice , Mice, Knockout , Phosphorylation
4.
Nat Commun ; 9(1): 1126, 2018 03 19.
Article in English | MEDLINE | ID: mdl-29555900

ABSTRACT

Neural crest migration is critical to its physiological function. Mechanisms controlling mammalian neural crest migration are comparatively unknown, due to difficulties accessing this cell population in vivo. Here we report requirements of glycogen synthase kinase 3 (GSK3) in regulating the neural crest in Xenopus and mouse models. We demonstrate that GSK3 is tyrosine phosphorylated (pY) in mouse neural crest cells and that loss of GSK3 leads to increased pFAK and misregulation of Rac1 and lamellipodin, key regulators of cell migration. Genetic reduction of GSK3 results in failure of migration. We find that pY-GSK3 phosphorylation depends on anaplastic lymphoma kinase (ALK), a protein associated with neuroblastoma. Consistent with this, neuroblastoma cells with increased ALK activity express high levels of pY-GSK3, and blockade of GSK3 or ALK can affect migration of these cells. Altogether, this work identifies a role for GSK3 in cell migration during neural crest development and cancer.


Subject(s)
Glycogen Synthase Kinase 3/metabolism , Neural Crest/cytology , Neural Crest/enzymology , Xenopus Proteins/chemistry , Anaplastic Lymphoma Kinase/antagonists & inhibitors , Anaplastic Lymphoma Kinase/metabolism , Animals , Cell Line, Tumor , Cell Lineage , Cell Movement/physiology , Female , Glycogen Synthase Kinase 3/chemistry , Glycogen Synthase Kinase 3/deficiency , Glycogen Synthase Kinase 3/genetics , Glycogen Synthase Kinase 3 beta/deficiency , Glycogen Synthase Kinase 3 beta/genetics , Glycogen Synthase Kinase 3 beta/metabolism , Humans , Mice , Mice, Knockout , Neural Crest/embryology , Neuroblastoma/enzymology , Phosphorylation , Pregnancy , Xenopus Proteins/metabolism , Xenopus laevis/embryology , Xenopus laevis/metabolism
5.
Sci Rep ; 7(1): 5781, 2017 07 18.
Article in English | MEDLINE | ID: mdl-28720858

ABSTRACT

Increasing evidence suggests that glycogen synthase kinase-3ß (GSK-3ß) plays a crucial role in neurodegenerative/psychiatric disorders, while pan-neural knockout of GSK-3ß also shows detrimental effects. Currently, the function of GSK-3ß in specific type of neurons is elusive. Here, we infused AAV-CaMKII-Cre-2A-eGFP into GSK-3ßlox/lox mice to selectively delete the kinase in excitatory neurons of hippocampal dentate gyrus (DG), and studied the effects on cognitive/psychiatric behaviors and the molecular mechanisms. We found that mice with GSK-3ß deletion in DG excitatory neurons displayed spatial and fear memory defects with an anti-anxiety behavior. Further studies demonstrated that GSK-3ß deletion in DG subset inhibited hippocampal synaptic transmission and reduced levels of GluN1, GluN2A and GluN2B (NMDAR subunits), GluA1 (AMPAR subunit), PSD93 and drebrin (postsynaptic structural proteins), and synaptophysin (presynaptic protein). GSK-3ß deletion also suppressed the activity-dependent neural activation and calcium/calmodulin-dependent protein kinase II (CaMKII)/CaMKIV-cAMP response element binding protein (CREB) signaling. Our data suggest that GSK-3ß in hippocampal DG excitatory neurons is essential for maintaining synaptic plasticity and memory.


Subject(s)
Dentate Gyrus/physiopathology , Glycogen Synthase Kinase 3/deficiency , Memory Disorders/physiopathology , Neuronal Plasticity/physiology , Neurons/physiology , Animals , Dentate Gyrus/metabolism , Glycogen Synthase Kinase 3/genetics , Maze Learning/physiology , Memory Disorders/genetics , Mice, Knockout , Mice, Transgenic , Nerve Tissue Proteins/metabolism , Neuronal Plasticity/genetics , Neurons/metabolism , Receptors, N-Methyl-D-Aspartate/genetics , Receptors, N-Methyl-D-Aspartate/metabolism , Signal Transduction/genetics , Synaptic Transmission/genetics , Synaptic Transmission/physiology , Synaptophysin/metabolism
6.
Circ Res ; 118(8): 1208-22, 2016 04 15.
Article in English | MEDLINE | ID: mdl-26976650

ABSTRACT

RATIONALE: Cardiac myocyte-specific deletion of either glycogen synthase kinase (GSK)-3α and GSK-3ß leads to cardiac protection after myocardial infarction, suggesting that deletion of both isoforms may provide synergistic protection. This is an important consideration because of the fact that all GSK-3-targeted drugs, including the drugs already in clinical trial target both isoforms of GSK-3, and none are isoform specific. OBJECTIVE: To identify the consequences of combined deletion of cardiac myocyte GSK-3α and GSK-3ß in heart function. METHODS AND RESULTS: We generated tamoxifen-inducible cardiac myocyte-specific mice lacking both GSK-3 isoforms (double knockout). We unexpectedly found that cardiac myocyte GSK-3 is essential for cardiac homeostasis and overall survival. Serial echocardiographic analysis reveals that within 2 weeks of tamoxifen treatment, double-knockout hearts leads to excessive dilatative remodeling and ventricular dysfunction. Further experimentation with isolated adult cardiac myocytes and fibroblasts from double-knockout implicated cardiac myocytes intrinsic factors responsible for observed phenotype. Mechanistically, loss of GSK-3 in adult cardiac myocytes resulted in induction of mitotic catastrophe, a previously unreported event in cardiac myocytes. Double-knockout cardiac myocytes showed cell cycle progression resulting in increased DNA content and multinucleation. However, increased cell cycle activity was rivaled by marked activation of DNA damage, cell cycle checkpoint activation, and mitotic catastrophe-induced apoptotic cell death. Importantly, mitotic catastrophe was also confirmed in isolated adult cardiac myocytes. CONCLUSIONS: Together, our findings suggest that cardiac myocyte GSK-3 is required to maintain normal cardiac homeostasis, and its loss is incompatible with life because of cell cycle dysregulation that ultimately results in a severe fatal dilated cardiomyopathy.


Subject(s)
Cardiomyopathy, Dilated/metabolism , Cardiomyopathy, Dilated/mortality , Glycogen Synthase Kinase 3/deficiency , Mitosis/physiology , Myocytes, Cardiac/metabolism , Animals , Cardiomyopathy, Dilated/pathology , Glycogen Synthase Kinase 3/genetics , Glycogen Synthase Kinase 3 beta , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Myocytes, Cardiac/pathology
7.
PLoS One ; 11(2): e0149604, 2016.
Article in English | MEDLINE | ID: mdl-26886780

ABSTRACT

The development of the mammalian skull is a complex process that requires multiple tissue interactions and a balance of growth and differentiation. Disrupting this balance can lead to changes in the shape and size of skull bones, which can have serious clinical implications. For example, insufficient ossification of the bony elements leads to enlarged anterior fontanelles and reduced mechanical protection of the brain. In this report, we find that loss of Gsk3ß leads to a fully penetrant reduction of frontal bone size and subsequent enlarged frontal fontanelle. In the absence of Gsk3ß the frontal bone primordium undergoes increased cell death and reduced proliferation with a concomitant increase in Fgfr2-IIIc and Twist1 expression. This leads to a smaller condensation and premature differentiation. This phenotype appears to be Wnt-independent and is not rescued by decreasing the genetic dose of ß-catenin/Ctnnb1. Taken together, our work defines a novel role for Gsk3ß in skull development.


Subject(s)
Frontal Bone/enzymology , Frontal Bone/pathology , Glycogen Synthase Kinase 3/metabolism , Animals , Biomarkers/metabolism , Cell Death , Cell Differentiation , Cell Movement , Cell Proliferation , Craniofacial Abnormalities/enzymology , Craniofacial Abnormalities/pathology , Embryo, Mammalian/pathology , Frontal Bone/embryology , Gene Deletion , Glycogen Synthase Kinase 3/deficiency , Glycogen Synthase Kinase 3/genetics , Glycogen Synthase Kinase 3 beta , Mice, Mutant Strains , Neural Crest/cytology , Osteoblasts/metabolism , Osteogenesis , RNA, Messenger/genetics , RNA, Messenger/metabolism , Signal Transduction , Wnt Proteins/metabolism , beta Catenin/metabolism
8.
Cancer Cell ; 29(1): 61-74, 2016 Jan 11.
Article in English | MEDLINE | ID: mdl-26766591

ABSTRACT

Initial pathway alternations required for pathogenesis of human acute myeloid leukemia (AML) are poorly understood. Here we reveal that removal of glycogen synthase kinase-3α (GSK-3α) and GSK-3ß dependency leads to aggressive AML. Although GSK-3α deletion alone has no effect, GSK-3ß deletion in hematopoietic stem cells (HSCs) resulted in a pre-neoplastic state consistent with human myelodysplastic syndromes (MDSs). Transcriptome and functional studies reveal that each GSK-3ß and GSK-3α uniquely contributes to AML by affecting Wnt/Akt/mTOR signaling and metabolism, respectively. The molecular signature of HSCs deleted for GSK-3ß provided a prognostic tool for disease progression and survival of MDS patients. Our study reveals that GSK-3α- and GSK-3ß-regulated pathways can be responsible for stepwise transition to MDS and subsequent AML, thereby providing potential therapeutic targets of disease evolution.


Subject(s)
Glycogen Synthase Kinase 3/metabolism , Hematopoietic Stem Cells/enzymology , Leukemia, Myeloid, Acute/enzymology , Animals , Disease Models, Animal , Glycogen Synthase Kinase 3/deficiency , Glycogen Synthase Kinase 3 beta , Humans , Leukemia, Myeloid, Acute/genetics , Leukemia, Myeloid, Acute/therapy , Mice, Transgenic , Proto-Oncogene Proteins c-akt/metabolism , Signal Transduction/physiology
9.
PLoS One ; 10(3): e0119524, 2015.
Article in English | MEDLINE | ID: mdl-25775433

ABSTRACT

Draxin is an important axon guidance cue necessary for the formation of forebrain commissures including the corpus callosum, but the molecular details of draxin signaling are unknown. To unravel how draxin signals are propagated we used murine cortical neurons and genetic and pharmacological approaches. We found that draxin-induced growth cone collapse critically depends on draxin receptors (deleted in colorectal cancer, DCC), inhibition of protein kinase B/Akt, activation of GSK-3ß (glycogen synthase kinase-3ß) and the presence of microtubule-associated protein MAP1B. This study, for the first time elucidates molecular events in draxin repulsion, links draxin and DCC to MAP1B and identifies a novel MAP1B-depenent GSK-3ß pathway essential for chemo-repulsive axon guidance cue signaling.


Subject(s)
Axons/physiology , Glycogen Synthase Kinase 3/metabolism , Intercellular Signaling Peptides and Proteins/metabolism , Microtubule-Associated Proteins/metabolism , Proto-Oncogene Proteins c-akt/metabolism , Animals , Cells, Cultured , DCC Receptor , Female , Glycogen Synthase Kinase 3/deficiency , Glycogen Synthase Kinase 3 beta , Male , Mice , Neurons/physiology , Receptors, Cell Surface/metabolism , Signal Transduction , Tumor Suppressor Proteins/metabolism
10.
Biol Reprod ; 92(3): 65, 2015 Mar.
Article in English | MEDLINE | ID: mdl-25568307

ABSTRACT

The signaling enzyme glycogen synthase kinase 3 (GSK3) exists as two isoforms-GSK3A and GSK3B. Protein phosphorylation by GSK3 has important signaling roles in several cells. In our past work, we found that both isoforms of GSK3 are present in mouse sperm and that catalytic GSK3 activity correlates with motility of sperm from several species. Here, we examined the role of Gsk3a in male fertility using a targeted gene knockout (KO) approach. The mutant mice are viable, but have a male infertility phenotype, while female fertility is unaffected. Testis weights of Gsk3a(-/-) mice are normal and sperm are produced in normal numbers. Although spermatogenesis is apparently unimpaired, sperm motility parameters in vitro are impaired. In addition, the flagellar waveform appears abnormal, characterized by low amplitude of flagellar beat. Sperm ATP levels were lower in Gsk3a(-/-) mice compared to wild-type animals. Protein phosphatase PP1 gamma2 protein levels were unaltered, but its catalytic activity was elevated in KO sperm. Remarkably, tyrosine phosphorylation of hexokinase and capacitation-associated changes in tyrosine phosphorylation of proteins are absent or significantly lower in Gsk3a(-/-) sperm. The GSK3B isoform was present and unaltered in testis and sperm of Gsk3a(-/-) mice, showing the inability of GSK3B to substitute for GSK3A in this context. Our studies show that sperm GSK3A is essential for male fertility. In addition, the GSK3A isoform, with its highly conserved glycine-rich N terminus in mammals, may have an isoform-specific role in its requirement for normal sperm motility and fertility.


Subject(s)
Glycogen Synthase Kinase 3/deficiency , Glycogen Synthase Kinase 3/physiology , Infertility, Male/etiology , Infertility, Male/physiopathology , Sperm Motility/physiology , Spermatozoa/physiology , Animals , Disease Models, Animal , Genotype , Glycogen Synthase Kinase 3/genetics , Infertility, Male/genetics , Isoenzymes , Male , Mice , Mice, Knockout , Mutation/genetics , Phenotype , Phosphorylation , Protein-Tyrosine Kinases/metabolism , Signal Transduction/genetics , Signal Transduction/physiology , Sperm Motility/genetics , Spermatogenesis/genetics , Spermatogenesis/physiology
11.
Mol Psychiatry ; 20(4): 482-9, 2015 Apr.
Article in English | MEDLINE | ID: mdl-24912492

ABSTRACT

Central nervous glycogen synthase kinase 3ß (GSK3ß) is implicated in a number of neuropsychiatric diseases, such as bipolar disorder, depression, schizophrenia, fragile X syndrome or anxiety disorder. Many drugs employed to treat these conditions inhibit GSK3ß either directly or indirectly. We studied how conditional knockout of GSK3ß affected structural synaptic plasticity. Deletion of the GSK3ß gene in a subset of cortical and hippocampal neurons in adult mice led to reduced spine density. In vivo imaging revealed that this was caused by a loss of persistent spines, whereas stabilization of newly formed spines was reduced. In electrophysiological recordings, these structural alterations correlated with a considerable drop in the frequency and amplitude of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor-dependent miniature excitatory postsynaptic currents. Expression of constitutively active ß-catenin caused reduction in spine density and electrophysiological alterations similar to GSK3ß knockout, suggesting that the effects of GSK3ß knockout were mediated by the accumulation of ß-catenin. In summary, changes of dendritic spines, both in quantity and in morphology, are correlates of experience-dependent synaptic plasticity; thus, these results may help explain the mechanism of action of psychotropic drugs inhibiting GSK3ß.


Subject(s)
Dendritic Spines/physiology , Excitatory Postsynaptic Potentials/genetics , Gene Expression Regulation/genetics , Glycogen Synthase Kinase 3/deficiency , Neurons/cytology , beta Catenin/metabolism , Animals , Antineoplastic Agents, Hormonal/pharmacology , Bacterial Proteins/genetics , Bacterial Proteins/metabolism , Cerebral Cortex/cytology , Excitatory Amino Acid Agents/pharmacology , Excitatory Postsynaptic Potentials/drug effects , GABA Antagonists/pharmacology , Gene Expression Regulation/drug effects , Glycogen Synthase Kinase 3/genetics , Glycogen Synthase Kinase 3 beta , Hippocampus/cytology , In Vitro Techniques , Luminescent Proteins/genetics , Luminescent Proteins/metabolism , Mice , Mice, Transgenic , Neurons/drug effects , Patch-Clamp Techniques , Picrotoxin/pharmacology , Tamoxifen/pharmacology
12.
Am J Pathol ; 184(12): 3394-404, 2014 Dec.
Article in English | MEDLINE | ID: mdl-25451156

ABSTRACT

Studies have implicated signaling through glycogen synthase kinase (GSK) 3α/ß in the activation of pro-atherogenic pathways and the accelerated development of atherosclerosis. By using a mouse model, we examined the role of GSK3α in the development and progression of accelerated atherosclerosis. We crossed Gsk3a/GSK3α-knockout mice with low-density lipoprotein receptor (Ldlr) knockout mice. Five-week-old Ldlr(-/-);Gsk3a(+/+), Ldlr(-/-);Gsk3a(+/-), and Ldlr(-/-);Gsk3a(-/-) mice were fed a chow diet or a high-fat diet for 10 weeks and then sacrificed. GSK3α deficiency had no detectible effect on any measured parameters in chow-fed mice. High-fat-diet fed Ldlr(-/-) mice that were deficient for GSK3α had significantly less hepatic lipid accumulation and smaller atherosclerotic lesions (60% smaller in Ldlr(-/-);Gsk3a(+/-) mice, 80% smaller in Ldlr(-/-);Gsk3a(-/-) mice; P < 0.05), compared with Ldlr(-/-);Gsk3a(+/+) controls. GSK3α deficiency was associated with a significant increase in plasma IL-10 concentration and IL-10 expression in isolated macrophages. A twofold to threefold enhancement in endoplasmic reticulum stress-induced IL-10 expression was observed in Thp-1-derived macrophages that were pretreated with the GSK3α/ß inhibitor CT99021. Together, these results suggest that GSK3α plays a pro-atherogenic role, possibly by mediating the effects of endoplasmic reticulum stress in the activation of pro-atherogenic pathways.


Subject(s)
Atherosclerosis/metabolism , Fatty Liver/metabolism , Glycogen Synthase Kinase 3/deficiency , Glycogen Synthase Kinase 3/genetics , Liver/pathology , Receptors, LDL/genetics , Animals , Atherosclerosis/genetics , Body Weight , Diet, High-Fat , Female , Genotype , Glycogen Synthase Kinase 3/metabolism , Glycogen Synthase Kinase 3 beta , Macrophages/metabolism , Mice , Mice, Inbred C57BL , Mice, Knockout , Mice, Transgenic , Receptors, LDL/deficiency , Signal Transduction
13.
Biosci Biotechnol Biochem ; 78(5): 800-5, 2014.
Article in English | MEDLINE | ID: mdl-25035982

ABSTRACT

Secretory defects cause transcriptional repression of both ribosomal proteins and ribosomal RNA genes in Saccharomyces cerevisiae. Rrs1, a trans-acting factor that participates in ribosome biogenesis, is involved in the signaling pathway induced by secretory defects. Here, we found that Rrs1 interacts with two homologs of the glycogen synthase kinase-3 (GSK-3), Rim11, and Mrk1. Rrs1 possesses a repetitive consensus amino acid sequence for phosphorylation by GSK-3, and mutation of this sequence abolished the interaction of Rrs1 with Rim11 and Mrk1. Although this mutation did not affect vegetative cell growth or secretory response, disruption of all four genes encoding GSK-3 homologs, especially Mck1, diminished the transcriptional repression of ribosomal protein genes in response to secretory defects. Among the four GSK-3 kinases, Mck1 appears to be the primary mediator of this response, while the other GSK-3 kinases contribute redundantly.


Subject(s)
Glycogen Synthase Kinase 3/metabolism , Ribosomes/metabolism , Saccharomyces cerevisiae/cytology , Saccharomyces cerevisiae/metabolism , Gene Deletion , Glycogen Synthase Kinase 3/deficiency , Glycogen Synthase Kinase 3/genetics , Nuclear Proteins/metabolism , Ribosomal Proteins/genetics , Saccharomyces cerevisiae/enzymology , Saccharomyces cerevisiae/genetics , Saccharomyces cerevisiae Proteins/metabolism , Transcription, Genetic/genetics
14.
PLoS One ; 8(6): e65125, 2013.
Article in English | MEDLINE | ID: mdl-23750237

ABSTRACT

Control of energy metabolism is an essential process for life. In insects, egg formation (oogenesis) and embryogenesis is dependent on stored molecules deposited by the mother or transcribed later by the zygote. In oviparous insects the egg becomes an isolated system after egg laying with all energy conversion taking place during embryogenesis. Previous studies in a few vector species showed a strong correlation of key morphogenetic events and changes in glucose metabolism. Here, we investigate glycogen and glucose metabolism in the red flour beetle Tribolium castaneum, an insect amenable to functional genomic studies. To examine the role of the key enzymes on glycogen and glucose regulation we cloned and analyzed the function of glycogen synthase kinase 3 (GSK-3) and hexokinase (HexA) genes during T. castaneum embryogenesis. Expression analysis via in situ hybridization shows that both genes are expressed only in the embryonic tissue, suggesting that embryonic and extra-embryonic cells display different metabolic activities. dsRNA adult female injection (parental RNAi) of both genes lead a reduction in egg laying and to embryonic lethality. Morphological analysis via DAPI stainings indicates that early development is impaired in Tc-GSK-3 and Tc-HexA1 RNAi embryos. Importantly, glycogen levels are upregulated after Tc-GSK-3 RNAi and glucose levels are upregulated after Tc-HexA1 RNAi, indicating that both genes control metabolism during embryogenesis and oogenesis, respectively. Altogether our results show that T. castaneum embryogenesis depends on the proper control of glucose and glycogen.


Subject(s)
Embryonic Development , Glucose/metabolism , Glycogen/metabolism , Tribolium/embryology , Tribolium/metabolism , Animals , Female , Gene Expression Regulation, Developmental , Genomics , Glycogen Synthase Kinase 3/deficiency , Glycogen Synthase Kinase 3/genetics , Glycogen Synthase Kinase 3/metabolism , Hexokinase/deficiency , Hexokinase/genetics , Hexokinase/metabolism , Mothers , Oogenesis/genetics , RNA Interference , Tribolium/enzymology , Tribolium/genetics
15.
Mol Brain ; 6: 27, 2013 May 25.
Article in English | MEDLINE | ID: mdl-23705847

ABSTRACT

BACKGROUND: GSK3ß is involved in a wide range of physiological functions, and is presumed to act in the pathogenesis of neurological diseases, from bipolar disorder to Alzheimer's disease (AD). In contrast, the GSK3α isozyme remained largely ignored with respect to both aspects. RESULTS: We generated and characterized two mouse strains with neuron-specific or with total GSK3α deficiency. Behavioral and electrophysiological analysis demonstrated the physiological importance of neuronal GSK3α, with GSK3ß not compensating for impaired cognition and reduced LTP. Interestingly, the passive inhibitory avoidance task proved to modulate the phosphorylation status of both GSK3 isozymes in wild-type mice, further implying both to function in cognition. Moreover, GSK3α contributed to the neuronal architecture of the hippocampal CA1 sub-region that is most vulnerable in AD. Consequently, practically all parameters and characteristics indicated that both GSK3 isoforms were regulated independently, but that they acted on the same physiological functions in learning and memory, in mobility and in behavior. CONCLUSIONS: GSK3α proved to be regulated independently from GSK3ß, and to exert non-redundant physiological neurological functions in general behavior and in cognition. Moreover, GSK3α contributes to the pathological phosphorylation of protein Tau.


Subject(s)
Cognition/physiology , Genetic Pleiotropy , Glycogen Synthase Kinase 3/deficiency , Glycogen Synthase Kinase 3/metabolism , tau Proteins/metabolism , Animals , Behavior, Animal , Body Weight , Brain/enzymology , Brain/pathology , Brain/physiopathology , CA1 Region, Hippocampal/enzymology , CA1 Region, Hippocampal/pathology , Crosses, Genetic , Female , Genotype , Glycogen Synthase Kinase 3 beta , Humans , Infertility, Male/enzymology , Infertility, Male/pathology , Integrases/metabolism , Isoenzymes/metabolism , Kaplan-Meier Estimate , Long-Term Potentiation , Male , Mice , Mice, Knockout , Motor Activity , Mutant Proteins/metabolism , Neurons/enzymology , Neurons/pathology , Organ Size , Organ Specificity , Phenotype , Phosphorylation
16.
Proc Natl Acad Sci U S A ; 109(50): 20732-7, 2012 Dec 11.
Article in English | MEDLINE | ID: mdl-23188793

ABSTRACT

Several studies in rodent models have shown that glycogen synthase kinase 3 ß (GSK3ß) plays an important role in the actions of antispychotics and mood stabilizers. Recently it was demonstrated that GSK3ß through a ß-arrestin2/protein kinase B (PKB or Akt)/protein phosphatase 2A (PP2A) signaling complex regulates dopamine (DA)- and lithium-sensitive behaviors and is required to mediate endophenotypes of mania and depression in rodents. We have previously shown that atypical antipsychotics antagonize DA D2 receptor (D2R)/ß-arrestin2 interactions more efficaciously than G-protein-dependent signaling, whereas typical antipsychotics inhibit both pathways with similar efficacy. To elucidate the site of action of GSK3ß in regulating DA- or lithium-sensitive behaviors, we generated conditional knockouts of GSK3ß, where GSK3ß was deleted in either DA D1- or D2-receptor-expressing neurons. We analyzed these mice for behaviors commonly used to test antipsychotic efficacy or behaviors that are sensitive to lithium treatment. Mice with deletion of GSK3ß in D2 (D2GSK3ß(-/-)) but not D1 (D1GSK3ß(-/-)) neurons mimic antipsychotic action. However, haloperidol (HAL)-induced catalepsy was unchanged in either D2GSK3ß(-/-) or D1GSK3ß(-/-) mice compared with control mice. Interestingly, genetic stabilization of ß-catenin, a downstream target of GSK3ß, in D2 neurons did not affect any of the behaviors tested. Moreover, D2GSK3ß(-/-) or D1GSK3ß(-/-) mice showed similar responses to controls in the tail suspension test (TST) and dark-light emergence test, behaviors which were previously shown to be ß-arrestin2- and GSK3ß-dependent and sensitive to lithium treatment. Taken together these studies suggest that selective deletion of GSK3ß but not stabilization of ß-catenin in D2 neurons mimics antipsychotic action without affecting signaling pathways involved in catalepsy or certain mood-related behaviors.


Subject(s)
Antipsychotic Agents/pharmacology , Arrestins/physiology , Dopaminergic Neurons/drug effects , Dopaminergic Neurons/physiology , Glycogen Synthase Kinase 3/deficiency , Lithium/pharmacology , Receptors, Dopamine D2/physiology , Animals , Aripiprazole , Behavior, Animal/drug effects , Behavior, Animal/physiology , Gene Knockout Techniques , Glycogen Synthase Kinase 3/genetics , Glycogen Synthase Kinase 3/physiology , Glycogen Synthase Kinase 3 beta , Mice , Mice, 129 Strain , Mice, Inbred C57BL , Mice, Knockout , Motor Activity/drug effects , Motor Activity/physiology , Piperazines/pharmacology , Quinolones/pharmacology , Signal Transduction , beta Catenin/physiology , beta-Arrestins
17.
Biochem J ; 447(1): 175-84, 2012 Oct 01.
Article in English | MEDLINE | ID: mdl-22849606

ABSTRACT

GSK3ß (glycogen synthase kinase 3ß) is a ubiquitous kinase that plays a key role in multiple intracellular signalling pathways, and increased GSK3ß activity is implicated in disorders ranging from cancer to Alzheimer's disease. In the present study, we provide the first evidence of increased hypothalamic signalling via GSK3ß in leptin-deficient Lep(ob/ob) mice and show that intracerebroventricular injection of a GSK3ß inhibitor acutely improves glucose tolerance in these mice. The beneficial effect of the GSK3ß inhibitor was dependent on hypothalamic signalling via PI3K (phosphoinositide 3-kinase), a key intracellular mediator of both leptin and insulin action. Conversely, neuron-specific overexpression of GSK3ß in the mediobasal hypothalamus exacerbated the hyperphagia, obesity and impairment of glucose tolerance induced by a high-fat diet, while having little effect in controls fed standard chow. These results demonstrate that increased hypothalamic GSK3ß signalling contributes to deleterious effects of leptin deficiency and exacerbates high-fat diet-induced weight gain and glucose intolerance.


Subject(s)
Eating/physiology , Glucose/metabolism , Glycogen Synthase Kinase 3/metabolism , Hypothalamus/enzymology , Animals , Arcuate Nucleus of Hypothalamus/enzymology , Arcuate Nucleus of Hypothalamus/physiology , Base Sequence , DNA Primers/genetics , Diet, High-Fat/adverse effects , Glucose Intolerance/enzymology , Glucose Intolerance/etiology , Glycogen Synthase Kinase 3/deficiency , Glycogen Synthase Kinase 3/genetics , Glycogen Synthase Kinase 3 beta , Humans , Hypothalamus/physiology , Leptin/deficiency , Leptin/genetics , Male , Mice , Mice, Knockout , Obesity/enzymology , Obesity/etiology , Signal Transduction , Weight Gain/physiology
18.
Circulation ; 125(1): 65-75, 2012 Jan 03.
Article in English | MEDLINE | ID: mdl-22086876

ABSTRACT

BACKGROUND: The molecular pathways that regulate the extent of ischemic injury and post-myocardial infarction (MI) remodeling are not well understood. We recently demonstrated that glycogen synthase kinase-3α (GSK-3α) is critical to the heart's response to pressure overload. However, the role, if any, of GSK-3α in regulating ischemic injury and its consequences is not known. METHODS AND RESULTS: MI was induced in wild-type (WT) versus GSK-3α((-/-)) (KO) littermates by left anterior descending coronary artery ligation. Pre-MI, WT, and KO hearts had comparable chamber dimensions and ventricular function, but as early as 1 week post-MI, KO mice had significantly more left ventricular dilatation and dysfunction than WT mice. KO mice also had increased mortality during the first 10 days post-MI (43% versus 22%; P=0.04), and postmortem examination confirmed cardiac rupture as the cause of most of the deaths. In the mice that survived the first 10 days, left ventricular dilatation and dysfunction remained worse in the KO mice throughout the study (8 weeks). Hypertrophy, fibrosis, and heart failure were all increased in the KO mice. Given the early deaths due to rupture and the significant reduction in left ventricular function evident as early as 1 week post-MI, we examined infarct size following a 48-hour coronary artery ligation and found it to be increased in the KO mice. This was accompanied by increased apoptosis in the border zone of the MI. This increased susceptibility to ischemic injury-induced apoptosis was also seen in cardiomyocytes isolated from the KO mice that were exposed to hypoxia. Finally, Bax translocation to the mitochondria and cytochrome C release into the cytosol were increased in the KO mice. CONCLUSION: GSK-3α confers resistance to ischemic injury, at least in part, via limiting apoptosis. Loss of GSK-3α promotes ischemic injury, increases risk of cardiac rupture, accentuates post-MI remodeling and left ventricular dysfunction, and increases the progression to heart failure. These findings are in striking contrast to multiple previous reports in which deletion or inhibition of GSK-3ß is protective.


Subject(s)
Glycogen Synthase Kinase 3/physiology , Heart Rupture/enzymology , Myocardial Infarction/enzymology , Ventricular Remodeling/physiology , Animals , Apoptosis Regulatory Proteins/deficiency , Apoptosis Regulatory Proteins/genetics , Apoptosis Regulatory Proteins/physiology , Cardiotonic Agents/metabolism , Cardiotonic Agents/therapeutic use , Cells, Cultured , Death , Glycogen Synthase Kinase 3/deficiency , Glycogen Synthase Kinase 3/genetics , Heart Rupture/genetics , Heart Rupture/mortality , Male , Mice , Mice, Knockout , Myocardial Infarction/genetics , Myocardial Infarction/mortality , Myocytes, Cardiac/enzymology , Myocytes, Cardiac/pathology , Ventricular Remodeling/genetics
19.
Dev Cell ; 21(6): 1038-50, 2011 Dec 13.
Article in English | MEDLINE | ID: mdl-22172670

ABSTRACT

Neutrophils, in response to a chemoattractant gradient, undergo dynamic F-actin remodeling, a process important for their directional migration or chemotaxis. However, signaling mechanisms for chemoattractants to regulate the process are incompletely understood. Here, we characterized chemoattractant-activated signaling mechanisms that regulate cofilin dephosphorylation and actin cytoskeleton reorganization and are critical for neutrophil polarization and chemotaxis. In neutrophils, chemoattractants induced phosphorylation and inhibition of GSK3 via both PLCß-PKC and PI3Kγ-AKT pathways, leading to the attenuation of GSK3-mediated phosphorylation and inhibition of the cofilin phosphatase slingshot2 and an increase in dephosphorylated, active cofilin. The relative contribution of this GSK3-mediated pathway to neutrophil chemotaxis regulation depended on neutrophil polarity preset by integrin-induced polarization of PIP5K1C. Therefore, our study characterizes a signaling mechanism for chemoattractant-induced actin cytoskeleton remodeling and elucidates its context-dependent role in regulating neutrophil polarization and chemotaxis.


Subject(s)
Actin Depolymerizing Factors/metabolism , Class Ib Phosphatidylinositol 3-Kinase/metabolism , Glycogen Synthase Kinase 3/metabolism , Neutrophils/physiology , Phospholipase C beta/metabolism , Phosphoprotein Phosphatases/metabolism , Actins/metabolism , Animals , Base Sequence , Cell Movement/physiology , Cell Polarity/physiology , Chemotaxis, Leukocyte/physiology , Gene Knockdown Techniques , Glycogen Synthase Kinase 3/deficiency , Glycogen Synthase Kinase 3/genetics , In Vitro Techniques , Integrins/metabolism , Mice , Mice, Knockout , Mice, Transgenic , Phospholipase C beta/deficiency , Phospholipase C beta/genetics , Phosphoprotein Phosphatases/deficiency , Phosphoprotein Phosphatases/genetics , Phosphorylation , Phosphotransferases (Alcohol Group Acceptor)/metabolism , Protein Kinase C/metabolism , Proto-Oncogene Proteins c-akt/metabolism , RNA, Small Interfering/genetics , Signal Transduction
20.
PLoS One ; 6(10): e25847, 2011.
Article in English | MEDLINE | ID: mdl-22022457

ABSTRACT

INTRODUCTION: The function of Glycogen Synthase Kinases 3ß (GSK-3ß) has previously been shown to be necessary for normal secondary palate development. Using GSK-3ß null mouse embryos, we examine the potential coordinate roles of Wnt and Hedgehog signaling on palatal ossification. METHODS: Palates were harvested from GSK-3ß, embryonic days 15.0-18.5 (e15.0-e18.5), and e15.5 Indian Hedgehog (Ihh) null embryos, and their wild-type littermates. The phenotype of GSK-3ß null embryos was analyzed with skeletal whole mount and pentachrome stains. Spatiotemporal regulation of osteogenic gene expression, in addition to Wnt and Hedgehog signaling activity, were examined in vivo on GSK-3ß and Ihh +/+ and -/- e15.5 embryos using in situ hybridization and immunohistochemistry. To corroborate these results, expression of the same molecular targets were assessed by qRT-PCR of e15.5 palates, or e13.5 palate cultures treated with both Wnt and Hedgehog agonists and anatagonists. RESULTS: GSK-3ß null embryos displayed a 48 percent decrease (*p<0.05) in palatine bone formation compared to wild-type littermates. GSK-3ß null embryos also exhibited decreased osteogenic gene expression that was associated with increased Wnt and decreased Hedgehog signaling. e13.5 palate culture studies demonstrated that Wnt signaling negatively regulates both osteogenic gene expression and Hedgehog signaling activity, while inhibition of Wnt signaling augments both osteogenic gene expression and Hedgehog signaling activity. In addition, no differences in Wnt signaling activity were noted in Ihh null embryos, suggesting that canonical Wnt may be upstream of Hedgehog in secondary palate development. Lastly, we found that GSK-3ß -/- palate cultures were "rescued" with the Wnt inhibitor, Dkk-1. CONCLUSIONS: Here, we identify a critical role for GSK-3ß in palatogenesis through its direct regulation of canonical Wnt signaling. These findings shed light on critical developmental pathways involved in palatogenesis and may lead to novel molecular targets to prevent cleft palate formation.


Subject(s)
Glycogen Synthase Kinase 3/metabolism , Mesoderm/embryology , Mesoderm/enzymology , Organogenesis , Osteogenesis , Palate/embryology , Palate/enzymology , Animals , Embryo, Mammalian/enzymology , Gene Expression Regulation, Developmental , Glycogen Synthase Kinase 3/deficiency , Glycogen Synthase Kinase 3 beta , Hedgehog Proteins/metabolism , Mice , Mice, Inbred C57BL , Mutation/genetics , Organogenesis/genetics , Osteogenesis/genetics , Phenotype , Up-Regulation , Wnt Signaling Pathway
SELECTION OF CITATIONS
SEARCH DETAIL
...